Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043891398> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2043891398 endingPage "P291" @default.
- W2043891398 startingPage "P291" @default.
- W2043891398 abstract "of results The five patients studied were all male, median age of 30 yrs (range 28–42), with no significant co-morbidities. Median baseline HIV viral load (VL) was 90,000 copies/ ml (range 11,759–3,035,664). Patients 1 and 2 with Burkitts Lymphoma, and Patient 3 with HIV-assoc DLBCL of anus (stage 1E) were treated with CODOX-M/IVAC; Patient 4 had high grade B cell lymphoma and received rCHOP. Each of these patients were treated with tenofovir/ emtricitabine and enfuvirtide. Patient 5 had plasmablastic high grade B cell NHL of the pancreas, which recurred in the leg. He received ESHAP/Ifosphamide/Cytarabine and his HAART regimen was zidovudine/lamivudine/tenofovir with enfuvirtide. Initial virological response was excellent in four patients, with all having more than 2 log drop in VL within the first 3–7 weeks of treatment. VL was undetectable within 12 weeks in Patients 1 and 2. Patient 4 initially did very well, followed by virological relapse. He subsequently admitted to poor compliance and resistance testing revealed lamivudine resistance. Patient 5 had an initial excellent virological response but the lymphoma progressed despite therapy and he died 8 weeks into treatment. Patient 3 had a 0.9 log drop in VL at week 5 and undetectable VL at week 19 which was then sustained throughout treatment. Two patients developed severe mucositis due to methotrexate, but none of the patients required dose reductions in their chemotherapy regimens. Two patients developed injection site reactions with enfuvirtide but continued to tolerate it for the duration of the chemotherapy. No patients developed renal dysfunction." @default.
- W2043891398 created "2016-06-24" @default.
- W2043891398 creator A5000337401 @default.
- W2043891398 creator A5014587516 @default.
- W2043891398 creator A5053114717 @default.
- W2043891398 creator A5053299136 @default.
- W2043891398 creator A5058900172 @default.
- W2043891398 date "2008-01-01" @default.
- W2043891398 modified "2023-09-27" @default.
- W2043891398 title "The use of enfuvirtide-based HAART regimens in HIV patients undergoing chemotherapy for lymphoma" @default.
- W2043891398 cites W2062889937 @default.
- W2043891398 doi "https://doi.org/10.1186/1758-2652-11-s1-p291" @default.
- W2043891398 hasPublicationYear "2008" @default.
- W2043891398 type Work @default.
- W2043891398 sameAs 2043891398 @default.
- W2043891398 citedByCount "0" @default.
- W2043891398 crossrefType "journal-article" @default.
- W2043891398 hasAuthorship W2043891398A5000337401 @default.
- W2043891398 hasAuthorship W2043891398A5014587516 @default.
- W2043891398 hasAuthorship W2043891398A5053114717 @default.
- W2043891398 hasAuthorship W2043891398A5053299136 @default.
- W2043891398 hasAuthorship W2043891398A5058900172 @default.
- W2043891398 hasBestOaLocation W20438913981 @default.
- W2043891398 hasConcept C126322002 @default.
- W2043891398 hasConcept C143998085 @default.
- W2043891398 hasConcept C147483822 @default.
- W2043891398 hasConcept C159047783 @default.
- W2043891398 hasConcept C177713679 @default.
- W2043891398 hasConcept C195616568 @default.
- W2043891398 hasConcept C203014093 @default.
- W2043891398 hasConcept C2776258796 @default.
- W2043891398 hasConcept C2776694085 @default.
- W2043891398 hasConcept C2778037500 @default.
- W2043891398 hasConcept C2779338263 @default.
- W2043891398 hasConcept C3013748606 @default.
- W2043891398 hasConcept C71924100 @default.
- W2043891398 hasConceptScore W2043891398C126322002 @default.
- W2043891398 hasConceptScore W2043891398C143998085 @default.
- W2043891398 hasConceptScore W2043891398C147483822 @default.
- W2043891398 hasConceptScore W2043891398C159047783 @default.
- W2043891398 hasConceptScore W2043891398C177713679 @default.
- W2043891398 hasConceptScore W2043891398C195616568 @default.
- W2043891398 hasConceptScore W2043891398C203014093 @default.
- W2043891398 hasConceptScore W2043891398C2776258796 @default.
- W2043891398 hasConceptScore W2043891398C2776694085 @default.
- W2043891398 hasConceptScore W2043891398C2778037500 @default.
- W2043891398 hasConceptScore W2043891398C2779338263 @default.
- W2043891398 hasConceptScore W2043891398C3013748606 @default.
- W2043891398 hasConceptScore W2043891398C71924100 @default.
- W2043891398 hasIssue "Suppl 1" @default.
- W2043891398 hasLocation W20438913981 @default.
- W2043891398 hasOpenAccess W2043891398 @default.
- W2043891398 hasPrimaryLocation W20438913981 @default.
- W2043891398 hasRelatedWork W1972774805 @default.
- W2043891398 hasRelatedWork W1973460911 @default.
- W2043891398 hasRelatedWork W2074694215 @default.
- W2043891398 hasRelatedWork W2096903645 @default.
- W2043891398 hasRelatedWork W2099959630 @default.
- W2043891398 hasRelatedWork W2371666691 @default.
- W2043891398 hasRelatedWork W2378355431 @default.
- W2043891398 hasRelatedWork W4232330754 @default.
- W2043891398 hasRelatedWork W4300854745 @default.
- W2043891398 hasRelatedWork W4301080166 @default.
- W2043891398 hasVolume "11" @default.
- W2043891398 isParatext "false" @default.
- W2043891398 isRetracted "false" @default.
- W2043891398 magId "2043891398" @default.
- W2043891398 workType "article" @default.